Analysts expect Niagen Bioscience, Inc. to report revenue of 33.13 M for Q3 26, against a range of 30.34 M to 35.92 M. The most recent reported quarter, Q2 26, came in at 29.79 M, a 1.4% beat against the 29.37 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 25.58 M | 29.13 M | 30.48 M | 31.12 M | 33.99 M | 33.84 M | 31.47 M | 29.79 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 25.08 M | 28.01 M | 27.67 M | 27.70 M | 35.09 M | 34.53 M | 35.31 M | 30.35 M | 35.92 M | 35.06 M | 38.89 M | 41.16 M | 42.34 M | 43.95 M | 39.32 M | 42.45 M | ||||||||||
| Low Estimate | 20.95 M | 23.48 M | 22.88 M | 25.97 M | 30.90 M | 30.58 M | 30.47 M | 28.38 M | 30.34 M | 31.58 M | 32.51 M | 35.63 M | 35.66 M | 39.89 M | 35.06 M | 37.07 M | ||||||||||
| Consensus Estimate | 23.02 M | 25.74 M | 25.28 M | 26.84 M | 32.99 M | 32.56 M | 32.89 M | 29.37 M | 33.13 M | 33.32 M | 35.70 M | 38.40 M | 39.00 M | 41.92 M | 37.19 M | 39.76 M |
Analysts expect Niagen Bioscience, Inc. to report earnings per share of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.01 , in line with the 0.01 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.03 | 0.09 | 0.06 | 0.04 | 0.05 | 0.05 | 0.07 | 0.01 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.08 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 | 0.05 | 0.04 | ||||||||||
| Low Estimate | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.06 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 | 0.05 | 0.04 | ||||||||||
| Consensus Estimate | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.07 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 | 0.05 | 0.04 |
Pull Wall Street consensus for Niagen Bioscience, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NAGE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NAGE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NAGE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();